NASDAQ : IMCC
IM Cannabis Corp. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · Israel
Last price 0.791 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.30M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
Details
| Name | IM Cannabis Corp. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 44 |
| Founded | 1980 |
| Ceo | Oren Shuster |
| Country | Canada |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| Isin | CA44969Q5059 |
| Cusip | 44969Q505 |
| Cik | 1792030 |
| Sic | 2833 |
Key executives
| Name | Title |
|---|---|
| Eyal Fisher | Chief Executive Officer of the IMC Holdings |
| Richard Balla | Chief Executive Officer of Adjupharm |
| Oren Shuster | Chief Executive Officer and Executive Director |
| Asi Levi | Chief Financial Officer |
| Anna Taranko | Director Investor and Public Relations |
Contact
| Address | 3606 – 833 Seymour Street, Vancouver, BC V6B 0G4, Canada |
| Website | https://imcannabis.com |